USA Today (2/23, Lloyd) reports that “another drug is getting a second life because of desirable side effects.” Lumigan [bimatoprost], “a drug Allergan produced to treat glaucoma,” has the side effect of producing “longer, thicker, and darker eyelashes.” The pharmaceutical company recently “developed a spinoff called Latisse, which the” Food and Drug Administration “approved for [...]

In a syndicated column in Canada’s Edmonton Sun (9/27), W. Gifford Jones, M.D., talked about complications associated with laser-assisted in situ keratomileusis (LASIK). While, “millions of North Americans have had this procedure done, and are happy with the result,” the Food and Drug Administration “wants stronger warnings of complications on patient information material.” The corneal [...]